MAM
HLVX

Martingale Asset Management’s HilleVax HLVX Stock Holding History

Martingale Asset Management’s Portfolio HLVX Stock Details HLVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-29,032
Closed -$420K – 812
2024
Q2 		$420K Hold
29,032
– – 0.01% 637
2024
Q1 		$483K Buy
29,032
+32
+0.1% +$512 0.01% 624
2023
Q4 		$465K Buy
29,000
+501
+2% +$6.66K 0.01% 629
2023
Q3 		$383K Buy
28,499
+16,220
+132% +$228K 0.01% 649
2023
Q2 		$211K Buy
+12,279
New +$190K ﹤0.01% 757

Other funds holding HLVX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Martingale Asset Management's HLVX Position: Q3 2024 in Review

Martingale Asset Management sold out of HilleVax (HLVX) in Q3 2024, closing a stake of 29,032 shares — an estimated $420K sold.

Martingale Asset Management first reported a position in HLVX in Q2 2023 and held it in 5 quarters. The position peaked at $483K in Q1 2024. 79 funds tracked by Wall St. Rank hold HLVX as of Q3 2024.

  • Martingale Asset Management reported no remaining HilleVax position as of Q3 2024 after selling out during the quarter.
  • Martingale Asset Management sold 29,032 HilleVax shares in Q3 2024, an estimated $420K.
  • Martingale Asset Management first reported a position in HilleVax in Q2 2023 and held it in 5 quarters.
  • Martingale Asset Management's HilleVax position peaked at $483K in Q1 2024.
  • 79 funds tracked by Wall St. Rank held HilleVax as of Q3 2024.

Based on Martingale Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.